School of Dentistry Studies Link Between Oral Health and Memory
... of WVU and now a researcher at the University of North Carolina ; Brenda L. Plassman, Ph.D., of Duke University , a nationally recognized scientist in the field of memory research; and Jersey Liang, Ph.D., a professor at the University of Michigan . Wu is the principal investigator. The ...Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients
... the prisms, which means that improved training in their use could further enhance the benefits, says principal investigator, Dr. Eli Peli, a senior scientist at Schepens Eye Research Institute and inventor of the glasses. The study, published in the May 2009 issue of Optometry and Vision Science, not ...Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
... autism. Now, alarmingly, vaccine preventable diseases are starting to come back." The Merieux Award is named for Dr. Charles Merieux, a French scientist and visionary who devoted his life to vaccines for the prevention of infectious disease. The company he developed from his father's laboratory ...Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain
... or by phone at 904-213-8232. A 3 oz. tube retails for $19.95. RZN Nutraceuticals is located in Miami, Florida. RZN Nutraceutical founder, Chief scientist Mark Lubin is a biomedical engineer who has 12 U.S. patents issued or pending for biomedical and technical innovations. For more information ...Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds
... "This deepens our understanding of the way immune privilege works," says Dr. Joan Stein Streilein, principal investigator of the study and senior scientist at Schepens Eye Research Institute. Immune privilege is a modification of the body's normal immune response. It protects the eye, the brain and ...FDA Stem Cell Approval Breakthrough Laudable
... Jan. 23 /PRNewswire/ -- Today the FDA announced approval for the first clinical trials on humans using Embryonic Stem Cells but Adult Stem Cell scientist Christian Drapeau says the experts may not be telling the whole story; Adult Stem Cells have greater potential with less risk. "While the FDA ...Phidea Srl and Marvin Research Srl Announce Completion of Merger
... product formulation, stability, clinical trial material manufacturing, and all phases of clinical research. Staffed with renown scientist and medical doctors, Phidea services major pharmaceutical companies seeking premium research in the European Union. About Marvin Research ...Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease
... the drug Dr. Bakshi has already tested, she is making her own drugs to attack this potentially important target." Dr. Bakshi is currently a scientist II in the Roskamp Institute and leads the Laboratory of Chemical Biology and Drug Discovery in Neurology. Prior to the Roskamp Institute, Dr. Bakshi ...Local Research Foundation Achieves Milestone in Fight Against Cancer
... to his mounting frustration with the traditional approach to cancer treatment, he developed a tripartnership concept between clinician, research scientist and patient, in which everyone works together to provide the best overall treatment. The CHRISTUS Stehlin Foundation conducts research that can be ...Wild Blueberries Take Top Spot in New Antioxidant Research Study
... antioxidant activity of the 25 fruits tested, as well as the highest total phenolic content and oxygen radical absorbance capacity (ORAC). Lead scientist Rui Hai Liu, Ph.D. used the cellular antioxidant activity (CAA) assay -- a new assay developed by the Cornell University Department of Food Science ...Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
... by the FDA. Napo expects to file its first NDA around mid-2009 for this indication, subject to the receipt of further funding. Dr. Pradip Bardhan, scientist and Head of Special Care Unit at ICDDR, B and the principal investigator, commented that "Crofelemer produces an impressive reduction in stool volume ...Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections
... The company expects to begin recruiting patients at its four international trial centres by the end of the year. Dr. Hans Schreier, Chief scientist of Axentis Pharma on the advances the company has made: "It was only very recently that we obtained all the necessary legal rights including transfer ...Video: Prognosis Split for Hip Fracture and Hip Replacement in the Elderly
... that the overall prognosis in elderly patients would be much worse than that of the younger patients," says Daisuke Ogino, Ph.D., senior visiting scientist in the Department of Medicine at Helsinki University Central Hospital and the primary author of the study. "It was a positive surprise that elderly ...Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
... academic interest. "We often tend to focus on just one organ, but here we see how an abnormal organ affects the whole organism," said behavioral scientist Rita J. Valentino, Ph.D., of The Children's Hospital of Philadelphia, who led the research describing how an overactive bladder altered nervous ...Video: Sanford Health's Journey to Cure Type 1 Diabetes Receives Major Boost
... and generosity has established a great pace for accomplishment for the Sanford Project. This will capture the attention of the best research scientist candidates from around the world. I am grateful, touched and inspired by this extraordinary leadership, and I add my heartfelt and sincere thanks ...OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
... Siemens A.G. and Thales. Dr. Postel has an extensive background in space propulsion systems and gas chemistry, beginning his career as a Staff scientist at Stanford University's Plasma Propulsion Lab. He later leveraged his expertise in these fields and founded a medical device start up in Cold Plasma ...Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
... CYT387 has also recently shown efficacy in a well-validated in-vivo model of myeloproliferative disorders in studies in the laboratory of physician- scientist Michael Deininger MD PhD at Oregon Health & Science University Cancer Institute, USA. Results showed a profound effects on abnormal blood counts and ...Seven-Year Neck Pain Study Sheds Light on Best Care
... when backing up a car," noted the study's lead author, Dr. David Cassidy, professor of epidemiology at the University of Toronto and senior scientist at the University Health Network at Toronto Western Hospital. For the minority of neck pain sufferers who experience Grade 3 neck pain -- that is ...Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
... in both plant and mammalian physiology. Dr Weir has a PhD from Auckland University and in 1997 was awarded an international award, the Young scientist of the Year by the International Society for Analytical Cytology. Dr Weir established the bioactives screening platform for HortResearch, a wholly ...Curemark Appoints Preeminent Pediatrics Gastroenterologist
... Dec. 18 /PRNewswire/ -- Curemark's Board of Directors announced today that Steven M. Schwarz, MD, FAAP, FACN, AGAF, will join the company as a senior scientist and will serve on the company's Scientific Advisory Board. Dr. Schwarz is presently Chairman of the Department of Pediatrics at The Long Island ...'Stereo' Mammography Takes Breast Imaging to a New Dimension
... of North America (RSNA). "Standard mammography is one of the most difficult radiographic exams to interpret," said David J. Getty, Ph.D., division scientist at BBN Technologies of Cambridge, Mass. "In a two-dimensional image of the breast, subtle lesions may be masked by underlying or overlying normal ...Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo
... cells is one of the most significant scientific findings of the last quarter century; more significant than cloning Dolly the sheep. Indeed, the scientist who originally cloned Dolly, Professor Ian Wilmut, recently stated that direct reprogramming is "extremely exciting and astonishing", a scientific ...Tumor Eradication Article Published by Cancer Research
... represents a significant advance in tumor therapy and diagnosis," said President and CEO Aladar A. Szalay, PhD, an internationally-recognized scientist who founded Genelux Corporation in 2001. The article, titled "Eradication of Solid Human Tumors in Nude Mice with an Intravenously Injected ...Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
... project director. In July 2006 the FTCR and PUBPAT challenged three patents held by WARF because they are hindering stem cell research. Stem Cell scientist Dr. Jeanne Loring supported the challenge, which led to the rejection of all claims of all three patents in March. In June WARF offered counter ...